CLIVE ROPER,
BSc PhD CBiol CSci ERT FRSB
Director, Roper Toxicology Consulting Limited
EXPERIENCE
March 2021 - Present
Director, Owner and Founder, Roper Toxicology Consulting Limited
April 2021 - Present
January 2021 - Present
UK NC3Rs
August 2010 - February 2020
Charles River Laboratories, Edinburgh, UK
People management
Multimillion dollar budget
Business and department growth
BD
NAMs development
In vitro skin absorption
In vitro respiratory toxicology
In vitro safety pharmacology
Genetic toxicology
In vitro metabolism
Speaker
Leader
3Rs working group (corporate)
Technology evaluation (corporate)
March 2020 - February 2021
Charles River Laboratories, Edinburgh, UK
People management
Multimillion dollar budget
Business and department growth
BD
NAMs development
In vitro skin absorption
In vitro respiratory toxicology
In vitro safety pharmacology
Advanced in vitro tissue models
Speaker
Leader
3Rs working group (corporate)
Technology evaluation (corporate)
June 1996 - August 2010
Charles River Laboratories Edinburgh Limited
Scientific Manager (January 2003 - August 2010)
Study Director (July 1997 - December 2002)
Research Officer (June 1996 - June 1997).
EDUCATION
October 1990 - April 1994
DOCTOR OF PHILOSOPHY
Department of Environmental and Occupational Medicine, Newcastle University & Unilever Research, Sharnbrook, Bedfordshire, UK.
In vitro skin absorption and toxicology
PhD thesis: In vitro approaches to the prediction of percutaneous absorption and metabolism: a study of ethoxylates.
September 1987 - June 1990
Department of Agricultural Biochemistry and Nutrition, Newcastle University.
Agricultural Biochemistry and Nutrition, BSc (Hons) 2:1.
BACHELOR OF SCIENCE HONOURS DEGREE
ACHIEVEMENTS
• Developing a NAM for respiratory toxicology, representing this to the US EPA Special Advisory Panel, receiving a personal invitation to attend the EPA NAM conferences, being acknowledged as an EPA stakeholder for their animal free 2035 plans and writing the NAM as a Case Study now accepted for publication by the OECD
• I am an active Member of the Board of both the North American 3Rs Collaborative (NA3RsC) and UK NC3Rs developing North American and UK 3Rs strategy
• 4 of my peer review papers are quoted in OECD test guidelines (OECD 428 and OECD 492)
